Acutus Medical, Inc.: Nasdaq/NYSE listing notice — Acutus Medical receives Nasdaq delisting notice for bid price below $1.00

Acutus Medical, Inc.

Received Nasdaq notice on May 1, 2023 for non-compliance with minimum bid price rule.
Has 180 days, until Oct 30, 2023, to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not compliant by Oct 30, may transfer to Nasdaq Capital Market for additional 180 days, subject to other listing standards.
Company monitoring options; no assurance of regaining compliance; delisting possible.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Acutus Medical, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

May 1, 2023, Acutus Medical, Inc. (“the Company”) received a notice from The Nasdaq Stock Market (“ Nasdaq ”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Global Market. The Company has 180 calendar days, or until October 30, 2023, to regain compliance with the minimum bid price requirement. To regain compliance, the m

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001628280-23-016179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.